newsfilter
← Latest News
ACCESS Newswire·

NeonMind Files New Provisional Patent Application Covering Novel Mechanism of Weight Loss

OAKVILLE, ON / ACCESSWIRE / March 22, 2022 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused on bringing innovative psychedelic-based treatments to peo